Phillip Lai

1.2k total citations · 2 hit papers
14 papers, 969 citations indexed

About

Phillip Lai is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Phillip Lai has authored 14 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Ophthalmology, 9 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Phillip Lai's work include Retinal Diseases and Treatments (9 papers), Retinal Development and Disorders (6 papers) and Retinal Imaging and Analysis (5 papers). Phillip Lai is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Retinal Development and Disorders (6 papers) and Retinal Imaging and Analysis (5 papers). Phillip Lai collaborates with scholars based in United States, Switzerland and Australia. Phillip Lai's co-authors include Roman G. Rubio, Zhengrong Li, Brandon Busbee, Allen C. Ho, Carl D. Regillo, Mark R. Wieland, Namrata Saroj, Linda Yau, Jeffrey S. Heier and Peter A. Campochiaro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Phillip Lai

13 papers receiving 933 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

2014 486 citations Allen C. Ho, Brandon Busbee et al. Ophthalmology profile →
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions

2012 373 citations Jeffrey S. Heier, Peter A. Campochiaro et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phillip Lai United States	6	916	695	132	49	28	14	969
Laura Sararols Spain	11	569 0.6×	322 0.5×	172 1.3×	43 0.9×	21 0.8×	22	633
Asheesh Tewari United States	11	686 0.7×	509 0.7×	164 1.2×	93 1.9×	39 1.4×	26	785
Irmela Mantel Switzerland	23	1.3k 1.5×	984 1.4×	223 1.7×	26 0.5×	38 1.4×	83	1.4k
Tommaso Bacci Italy	13	498 0.5×	281 0.4×	122 0.9×	43 0.9×	35 1.3×	33	623
Yehia Hashad United States	11	1.6k 1.8×	1.1k 1.6×	138 1.0×	24 0.5×	15 0.5×	17	1.7k
Vlassis G. Grigoropoulos Greece	14	689 0.8×	579 0.8×	117 0.9×	152 3.1×	18 0.6×	30	738
Lucian Del Priore United States	8	369 0.4×	226 0.3×	165 1.3×	25 0.5×	19 0.7×	12	468
Makoto Shirasawa Japan	13	832 0.9×	607 0.9×	110 0.8×	21 0.4×	19 0.7×	19	913
Yukihiko Suzuki Japan	11	465 0.5×	282 0.4×	76 0.6×	52 1.1×	23 0.8×	34	500
Allison R. Ayala United States	13	1.5k 1.7×	1.4k 2.0×	223 1.7×	12 0.2×	17 0.6×	24	1.7k

Countries citing papers authored by Phillip Lai

Since Specialization

Citations

This map shows the geographic impact of Phillip Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Lai more than expected).

Fields of papers citing papers by Phillip Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Lai. The network helps show where Phillip Lai may publish in the future.

Co-authorship network of co-authors of Phillip Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Lai. A scholar is included among the top collaborators of Phillip Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Lai. Phillip Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Eichenbaum, David, Arshad M. Khanani, Dante J. Pieramici, et al.. (2025). Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. American Journal of Ophthalmology. 275. 14–26.

Chang, Dolly S., Natalia F. Callaway, Karl G. Csaky, et al.. (2023). Macular Sensitivity Endpoints in Geographic Atrophy. SHILAP Revista de lepidopterología. 4(1). 100351–100351. 22 indexed citations

Stockwell, Amy, Simon S. Gao, Ivaylo Stoilov, et al.. (2023). Rare CIDEC coding variants enriched in age-related macular degeneration patients with small low-luminance deficit cause lipid droplet and fat storage defects. PLoS ONE. 18(4). e0280484–e0280484. 4 indexed citations

Khanani, Arshad M., Vrinda Hershberger, Dante J. Pieramici, et al.. (2021). Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration. American Journal of Ophthalmology. 232. 49–57. 24 indexed citations

Tom, Irene, Victoria C. Pham, Kenneth J. Katschke, et al.. (2020). Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy. Proceedings of the National Academy of Sciences. 117(18). 9952–9963. 40 indexed citations

Pieramici, Dante J., Arshad M. Khanani, Flávia Brunstein, et al.. (2020). Phase 1 safety study of intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a novel serine protease inhibitor, in patients with Geographic Atrophy (GA). Investigative Ophthalmology & Visual Science. 61(7). 1942–1942. 1 indexed citations

Friesenhahn, Michel, Christina Rabe, Simon S. Gao, et al.. (2020). Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA). Investigative Ophthalmology & Visual Science. 61(7). 2988–2988. 2 indexed citations

Dere, Edward, Susan Crowell, Maurício Maia, et al.. (2020). Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic Atrophy. Toxicologic Pathology. 49(3). 610–620. 5 indexed citations

Booler, Helen, Nardos G. Tassew, Christopher Frantz, et al.. (2019). Functional and Ultrastructural Assessment of Novel OCT Findings in the Cynomolgus Monkey. Investigative Ophthalmology & Visual Science. 60(9). 186–186. 1 indexed citations

10.

Yaspan, Brian L., Zhengrong Li, Amy Dressen, et al.. (2014). A Common SNP at the CFI Locus is Associated with Rapid Progression of Geographic Atrophy. Investigative Ophthalmology & Visual Science. 55(13). 2234–2234. 4 indexed citations

11.

Ho, Allen C., Brandon Busbee, Carl D. Regillo, et al.. (2014). Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration. Ophthalmology. 121(11). 2181–2192. 486 indexed citations breakdown →

12.

Avery, Robert L., et al.. (2013). Meta-analysis examining the systemic safety profile of intravitreal ranibizumab injections in AMD, RVO and DME. Investigative Ophthalmology & Visual Science. 54(15). 1535–1535. 3 indexed citations

13.

Coulson, Chris, David D. Pothier, Phillip Lai, & John Rutka. (2012). Bismuth iodoform paraffin paste hypersensitivity reactions in mastoid cavities following isolation of mucosal lining: a series of 587 patients. The Journal of Laryngology & Otology. 126(3). 240–243. 4 indexed citations

14.

Heier, Jeffrey S., Peter A. Campochiaro, Linda Yau, et al.. (2012). Ranibizumab for Macular Edema Due to Retinal Vein Occlusions. Ophthalmology. 119(4). 802–809. 373 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact